Global Clinical Professionals

St. Petersburg, Florida 33714

4 studies enrolling now · 8 studies all time

What they study most

COVID-19, Hepatic Cirrhosis, Hepatic Encephalopathy (HE), Influenza, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Non-segmental Vitiligo, SARS-CoV-2, Severe Hepatic Impairment

Studies at this site

• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis — Recruiting now
• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo — Recruiting now
• A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease — Starting soon
• A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza — Running, not enrolling
• A Study of S-892216 in Participants With COVID-19 — Completed
• An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of EQ143 — Completed
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) — Completed